Keystone Wealth Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
9,081
-1,515
-14% -$39.6K 0.04% 302
2026
Q1
$298K Sell
10,596
-63
-0.6% -$1.68K 0.06% 247
2025
Q4
$265K Buy
10,659
+1,105
+12% +$27.9K 0.06% 208
2025
Q3
$243K Sell
9,554
-38
-0.4% -$938 0.05% 264
2025
Q2
$233K Sell
9,592
-39
-0.4% -$910 0.06% 252
2025
Q1
$244K Buy
9,631
+5
+0.1% +$131 0.07% 234
2024
Q4
$255K Sell
9,626
-178
-2% -$4.83K 0.07% 221
2024
Q3
$284K Sell
9,804
-163
-2% -$4.75K 0.08% 211
2024
Q2
$279K Buy
9,967
+144
+1% +$3.96K 0.09% 187
2024
Q1
$273K Sell
9,823
-4,262
-30% -$118K 0.09% 180
2023
Q4
$406K Sell
14,085
-2,355
-14% -$71.2K 0.14% 139
2023
Q3
$545K Sell
16,440
-1,208
-7% -$42.7K 0.21% 107
2023
Q2
$647K Sell
17,648
-222
-1% -$8.64K 0.24% 91
2023
Q1
$729K Buy
17,870
+19
+0.1% +$821 0.3% 81
2022
Q4
$915K Buy
17,851
+208
+1% +$9.97K 0.4% 56
2022
Q3
$772K Buy
17,643
+512
+3% +$24.9K 0.36% 60
2022
Q2
$898K Sell
17,131
-888
-5% -$45.3K 0.4% 55
2022
Q1
$933K Sell
18,019
-492
-3% -$25.5K 0.37% 63
2021
Q4
$1.09M Buy
+18,511
New +$917K 0.44% 57

Other funds holding PFE

Keystone Wealth Services's PFE Position: Q2 2026 in Review

Keystone Wealth Services reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $39.6K and leaving 9,081 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #302.

Keystone Wealth Services first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.09M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Keystone Wealth Services held 9,081 shares of Pfizer worth $219K as of Q2 2026.
  • Keystone Wealth Services sold 1,515 Pfizer shares in Q2 2026, an estimated $39.6K.
  • Pfizer made up 0.04% of Keystone Wealth Services's portfolio in Q2 2026, its #302 holding.
  • Keystone Wealth Services first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Keystone Wealth Services's Pfizer position peaked at $1.09M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Keystone Wealth Services's 13F filing for Q2 2026, filed 5 Aug 2026.